floatz

About floatz

✅ 🔍 Why We’re Here Biotech investing is high-stakes. Yet, most decisions still rely on slow, subjective diligence, leaving investors exposed to hidden scientific risks that drive costly failures. floatz exists to change that. We help life science investors move from uncertainty to conviction with fast, auditable, and objective scientific diligence—so capital flows to the science that truly matters. ✅ 🧠 How We Do It We combine advanced AI reasoning with human expertise. Our proprietary platform uses a biomedical Knowledge Graph and Graph Neural Networks to uncover non-obvious risks and opportunities hidden in complex data. Every insight is then validated by a PhD scientist, ensuring strategic nuance and scientific rigor. This synergy, machine-scale reasoning plus expert judgment, delivers a new standard of diligence: transparent, defensible, and investment-grade. ✅ 🚀 What We Offer We deliver Target & MoA Viability Reports designed for high-stakes investment decisions: ➡️ Viability Score & Go/No-Go Recommendation Quantitative risk assessment backed by relational reasoning. ➡️ Evidence Ledger Every conclusion is fully auditable, linked to its source. ➡️ Comprehensive Scientific Landscape From target validation to competitive IP mapping and contradiction analysis. ✅ 🤝 Partner with Us Ready to make smarter bets and avoid costly failures? Let’s redefine diligence together. 📩 founders@floatz.ai 🌐 floatz.ai

View contact profiles from floatz